Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2015, Article ID 947403, 4 pages
http://dx.doi.org/10.1155/2015/947403
Case Report

Successful Treatment of Bulla with Endobronchial Valves

1Department of Chest Diseases, Yedikule Chest Disease and Chest Surgery Education and Research Hospital, İstanbul, Turkey
2Amasya Merzifon Kara Mustafa Pasa State Hospital, Amasya, Turkey
3Dr. Burhan Nalbantoğlu State Hospital, Lefkose, Northern Cyprus, Turkey
4Karabük University Education and Research Hospital, Karabuk, Turkey

Received 31 May 2015; Revised 23 July 2015; Accepted 30 July 2015

Academic Editor: Tomonobu Koizumi

Copyright © 2015 Erdoğan Çetinkaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Emphysematous bullae are a complication of end-stage COPD. Patients with large bullae and poor respiratory function have limited treatment options. Surgical resection is a recognized treatment, but functional improvement after bullectomy is not satisfactory in patients with forced expiratory volume in 1 s (FEV1) < 35% predicted. When this 59-year-old male end-stage COPD patient was assessed, he was cachectic and lung function tests showed a FEV1 of 0.56 L (19% predicted) and a RV of 7 L (314% predicted), while 6MWT was 315 m and MRC dyspnea score was 4. Chest X-ray revealed a massive bulla of 10 cm in diameter in the right middle lobe. A fibrobronchoscopy was performed under local anesthesia and 2 Zephyr 4.0 valves were placed in the right middle lobe. Chest X-ray and CT scan performed 36 days later showed the complete resolution of the bulla. Seven months later, the patient demonstrated an improvement in FEV1 (+30%) and a decrease in RV from 314 to 262% predicted. This case report shows that the Zephyr valves may be successfully used to treat a large bulla in the right middle lobe in a patient with diffuse emphysema and severely impaired lung function.